Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Deworming through doctor visits: a smarter way to fight worms?

NCT ID NCT07507461

Knowledge-focused Sponsor: Amref Health Africa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving deworming drugs during regular healthcare visits works better than the usual special campaigns. Over 1,200 people in Western Kenya took part, including community members, health workers, and officials. Researchers measured how practical, affordable, and well-covered this integrated approach was compared to the standard method.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show a more sustainable and cost-effective way to deliver deworming treatment through existing health systems, reducing worm infections in communities.
What could go wrong
This is a completed case study, not a controlled trial of a new drug. Results may not apply to other regions or diseases, and the approach depends on local health system strength.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,229 people

The number who actually took part.

Started

May 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria 1. All eligible community members, including school-age children (SAC; 5-14 years) and adults (15 years and above) receiving targeted treatment for SCH. 2. Preschool-age children (PRESAC; 1-4 years), school-age children (SAC; 5-14 years), and adults (15 years and above) receiving targeted treatment for STH. 3. Must be residents of the target counties (Vihiga, Kakamega, Bungoma, and Trans-Nzoia). Exclusion Criteria Residents in wards outside the 122 non-Interruption of Transmission (non-IoT) wards.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Schistosomiasis infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

helminthiasis Infections schistosomiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Schistosomiasis infection Soil transmitted helminth (STH) infections

Contacts and locations

Locations

  • Community Based, no facility

    Kakamega, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.